{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:14:53Z","timestamp":1762492493423,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ijcha.2021.100753","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T13:05:42Z","timestamp":1616159142000},"page":"100753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Difference in risk factors of silent brain infarction between paroxysmal and persistent atrial fibrillation"],"prefix":"10.1016","volume":"33","author":[{"given":"Andrew T","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sera","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomotaka","family":"Yoshiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Nonin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asahiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Izumiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Yoshiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2021.100753_b0005","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: A global burden of disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.ijcha.2021.100753_b0010","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation (atria) study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA."},{"key":"10.1016\/j.ijcha.2021.100753_b0015","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: The framingham heart study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation."},{"key":"10.1016\/j.ijcha.2021.100753_b0020","doi-asserted-by":"crossref","unstructured":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials, Arch Intern Med. 154 (1994) 1449-1457.","DOI":"10.1001\/archinte.1994.00420130036007"},{"key":"10.1016\/j.ijcha.2021.100753_b0025","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/hrt.2002.008748","article-title":"Cost of an emerging epidemic: An economic analysis of atrial fibrillation in the UK","volume":"90","author":"Stewart","year":"2004","journal-title":"Heart."},{"key":"10.1016\/j.ijcha.2021.100753_b0030","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: The framingham study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke."},{"key":"10.1016\/j.ijcha.2021.100753_b0035","first-page":"840","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort","volume":"271","author":"Benjamin","year":"1994","journal-title":"The framingham heart study, JAMA."},{"key":"10.1016\/j.ijcha.2021.100753_b0040","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.ijcha.2021.100753_b0045","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.ijcha.2021.100753_b0050","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1474-4422(07)70170-9","article-title":"Silent brain infarcts: A systematic review","volume":"6","author":"Vermeer","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ijcha.2021.100753_b0055","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jamaneurol.2018.1073","article-title":"Advances in understanding the pathophysiology of lacunar stroke: A review","volume":"75","author":"Regenhardt","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ijcha.2021.100753_b0060","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1212\/WNL.57.7.1222","article-title":"Silent mri infarcts and the risk of future stroke: The cardiovascular health study","volume":"57","author":"Bernick","year":"2001","journal-title":"Neurology."},{"key":"10.1016\/j.ijcha.2021.100753_b0065","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/01.STR.0000068408.82115.D2","article-title":"Silent brain infarcts and white matter lesions increase stroke risk in the general population: The rotterdam scan study","volume":"34","author":"Vermeer","year":"2003","journal-title":"Stroke."},{"key":"10.1016\/j.ijcha.2021.100753_b0070","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa022066","article-title":"Silent brain infarcts and the risk of dementia and cognitive decline","volume":"348","author":"Vermeer","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ijcha.2021.100753_b0075","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jacc.2013.05.074","article-title":"Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function","volume":"62","author":"Gaita","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.ijcha.2021.100753_b0080","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1161\/STROKEAHA.114.005243","article-title":"Atrial fibrillation and cognitive decline-the role of subclinical cerebral infarcts: The atherosclerosis risk in communities study","volume":"45","author":"Chen","year":"2014","journal-title":"Stroke."},{"key":"10.1016\/j.ijcha.2021.100753_b0085","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/M14-0538","article-title":"Association between atrial fibrillation and silent cerebral infarctions: A systematic review and meta-analysis","volume":"161","author":"Kalantarian","year":"2014","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.ijcha.2021.100753_b0090","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.STR.29.5.913","article-title":"Cigarette smoking and other risk factors for silent cerebral infarction in the general population","volume":"29","author":"Howard","year":"1998","journal-title":"Stroke."},{"key":"10.1016\/j.ijcha.2021.100753_b0095","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/01.HYP.36.1.73-a","article-title":"Prevalence and risk factors of silent cerebral infarction in apparently normal adults","volume":"36","author":"Lee","year":"2000","journal-title":"Hypertension."},{"key":"10.1016\/j.ijcha.2021.100753_b0100","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.amjcard.2013.11.011","article-title":"Prevalence of and risk factors for silent ischemic stroke in patients with atrial fibrillation as determined by brain magnetic resonance imaging","volume":"113","author":"Cha","year":"2014","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.ijcha.2021.100753_b0105","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ahj.2015.03.016","article-title":"Predictors of silent brain infarction on magnetic resonance imaging in patients with nonvalvular atrial fibrillation: A transesophageal echocardiographic study","volume":"169","author":"Sugioka","year":"2015","journal-title":"Am Heart J."},{"key":"10.1016\/j.ijcha.2021.100753_b0110","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2019.03.013","article-title":"Risk factors and localization of silent cerebral infarction in patients with atrial fibrillation","volume":"16","author":"Miki","year":"2019","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcha.2021.100753_b0115","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/ehjci\/jew220","article-title":"Relationship between tissue doppler measurements of left ventricular diastolic function and silent brain infarction in patients with non-valvular atrial fibrillation","volume":"18","author":"Ishikawa","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"10.1016\/j.ijcha.2021.100753_b0120","first-page":"65","article-title":"Atrial fibrillation and silent stroke: Links, risks, and challenges","volume":"12","author":"Hahne","year":"2016","journal-title":"Vasc Health Risk Manag."},{"issue":"2014","key":"10.1016\/j.ijcha.2021.100753_b0125","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: Executive summary: A report of the american college of cardiology\/american heart association task force on practice guidelines and the heart rhythm society","volume":"130","author":"January","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.ijcha.2021.100753_b0130","doi-asserted-by":"crossref","unstructured":"Chapter 1: Definition and classification of CKD, Kidney International Supplements. 3 (2013) 19-62. doi: 10.1038\/kisup.2012.64.","DOI":"10.1038\/kisup.2012.64"},{"key":"10.1016\/j.ijcha.2021.100753_b0135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest."},{"key":"10.1016\/j.ijcha.2021.100753_b0140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the american society of echocardiography and the european association of cardiovascular imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J Am Soc Echocardiogr."},{"key":"10.1016\/j.ijcha.2021.100753_b0145","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/0002-9149(90)90330-4","article-title":"Prevalence and clinical implications of atrial spontaneous contrast in patients undergoing transesophageal echocardiography","volume":"65","author":"Castello","year":"1990","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.ijcha.2021.100753_b0150","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0735-1097(94)90644-0","article-title":"Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo","volume":"23","author":"Fatkin","year":"1994","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.ijcha.2021.100753_b0155","first-page":"1622","article-title":"Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation","volume":"31","author":"Zabalgoitia","year":"1998","journal-title":"Stroke prevention in atrial fibrillation iii investigators, J Am Coll Cardiol."},{"key":"10.1016\/j.ijcha.2021.100753_b0160","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.09.004","article-title":"Silent cerebral infarcts and cerebral white matter lesions in patients with nonvalvular atrial fibrillation","volume":"21","author":"Kobayashi","year":"2012","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"10.1016\/j.ijcha.2021.100753_b0165","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.STR.0000052631.98405.15","article-title":"Incidence and risk factors of silent brain infarcts in the population-based rotterdam scan study","volume":"34","author":"Vermeer","year":"2003","journal-title":"Stroke."},{"key":"10.1016\/j.ijcha.2021.100753_b0170","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1161\/01.STR.0000089684.41902.CD","article-title":"Greater impact of coexistence of hypertension and diabetes on silent cerebral infarcts","volume":"34","author":"Eguchi","year":"2003","journal-title":"Stroke."},{"issue":"2016","key":"10.1016\/j.ijcha.2021.100753_b0175","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"ESC guidelines for the management of atrial fibrillation developed in collaboration with eacts","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.ijcha.2021.100753_b0180","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jns.2008.04.029","article-title":"Cerebral small vessel disease and chronic kidney disease (CKD): Results of a cross-sectional study in community-based japanese elderly","volume":"272","author":"Wada","year":"2008","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.ijcha.2021.100753_b0185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/ndt\/gfn419","article-title":"Relationship between silent brain infarction and chronic kidney disease","volume":"24","author":"Kobayashi","year":"2009","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.ijcha.2021.100753_b0190","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1681\/ASN.V133806","article-title":"Role of the microvascular endothelium in progressive renal disease","volume":"13","author":"Kang","year":"2002","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.ijcha.2021.100753_b0195","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/01.HYP.0000168052.00426.65","article-title":"Relationship between aortic stiffening and microvascular disease in brain and kidney: Cause and logic of therapy","volume":"46","author":"O'Rourke","year":"2005","journal-title":"Hypertension."},{"key":"10.1016\/j.ijcha.2021.100753_b0200","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.ajkd.2005.09.029","article-title":"The determinants of endothelial dysfunction in CKD: Oxidative stress and asymmetric dimethylarginine","volume":"47","author":"Yilmaz","year":"2006","journal-title":"Am J Kidney Dis."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906721000415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906721000415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:09:38Z","timestamp":1762492178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906721000415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":40,"alternative-id":["S2352906721000415"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2021.100753","relation":{},"ISSN":["2352-9067"],"issn-type":[{"type":"print","value":"2352-9067"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Difference in risk factors of silent brain infarction between paroxysmal and persistent atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2021.100753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100753"}}